Back
Actinium Pharmaceuticals 10K Form
Sell
48
ATNM
Actinium Pharmaceuticals
Last Price:
6.23
Seasonality Move:
-2.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATNM News And Ratings
See the #1 stock for the next 7 days that we like better than ATNM
ATNM Financial Statistics
Sales & Book Value
Annual Sales: | $1.03M |
---|---|
Cash Flow: | $-13.69M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.97 |
Price / Book: | 3.2 |
Profitability
EPS (TTM): | -1.82000 |
---|---|
Net Income (TTM): | $-46.34M |
Gross Margin: | $0 |
Return on Equity: | 0% |
Return on Assets: | 0% |
Actinium Pharmaceuticals Earnings Forecast
Key Actinium Pharmaceuticals Financial Ratios
- The Selling, General & Administrative Expenses for ATNM have been equal to 1,165.05% of Gross Profit Margin.
- The Research & Development expenses have been 2,246.60% of Revenue.
- The Interest Expense is -0.04% of Operating Income.
- Per Share Earnings over the last 17 years have been positive in 9 years.
Actinium Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYAM |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | ATNM |
CUSIP: | 00507W |
Website: | actiniumpharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
ATNM Technical Analysis vs Fundamental Analysis
Sell
48
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy or a Sell?
-
Actinium Pharmaceuticals stock is rated a Sell
The current Actinium Pharmaceuticals [ATNM] share price is $6.30. The Score for ATNM is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.